Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Plos One
|
May 5, 2015
Assessing the Long-Term Impact of Treating Hepatitis C Virus (HCV)-Infected People Who Inject Drugs in the UK and the Relationship between Treatment Uptake and Efficacy on Future Infections
Hayley Bennett, Phil McEwan, Daniel Sugrue, et al.
International Journal of Clinical Practice
|
December 17, 2020
Risk factors associated with the incidence and recurrence of hyperkalaemia in patients with cardiorenal conditions
Eskinder Tafesse, Michael Hurst, Louise Hoskin, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
October 20, 2020
Serum potassium as a predictor of adverse clinical outcomes in patients with increasing comorbidity burden
Eskinder Tafesse, Michael Hurst, Daniel Sugrue, et al.
Renal Failure
|
January 22, 2021
The effect of hyperkalemia and long inter-dialytic interval on morbidity and mortality in patients receiving hemodialysis: a systematic review
Danai Bem, Daniel Sugrue, Ben Wilding, et al.
The Journal of General Virology
|
January 8, 2014
Human cytomegalovirus suppresses Fas expression and function
Sepehr Seirafian, Virginie Prod'homme, Daniel Sugrue, et al.
Journal of Managed Care & Specialty Pharmacy
|
February 4, 2020
Estimating HIV Management and Comorbidity Costs Among Aging HIV Patients in the United States: A Systematic Review
Thomas Ward, Daniel Sugrue, Olivia Hayward, et al.
Advances in Therapy
|
January 12, 2021
Costs and Healthcare Resource Use Associated with Risk of Cardiovascular Morbidity in Patients with Chronic Kidney Disease: Evidence from a Systematic Literature Review
Oliver Darlington, Carissa Dickerson, Marc Evans, et al.
BMC Rheumatology
|
February 4, 2021
Outcomes in rheumatoid arthritis patients treated with abatacept: a UK multi-centre observational study
Ernest Choy, Lara Groves, Daniel Sugrue, et al.
Plos Pathogens
|
April 16, 2015
Plasma membrane profiling defines an expanded class of cell surface proteins selectively targeted for degradation by HCMV US2 in cooperation with UL141
Jye-Lin Hsu, Dick J H van den Boomen, Peter Tomasec, et al.
Plos Pathogens
|
May 3, 2014
Two novel human cytomegalovirus NK cell evasion functions target MICA for lysosomal degradation
Ceri A Fielding, Rebecca Aicheler, Richard J Stanton, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Plos One
|
May 5, 2015
Assessing the Long-Term Impact of Treating Hepatitis C Virus (HCV)-Infected People Who Inject Drugs in the UK and the Relationship between Treatment Uptake and Efficacy on Future Infections
Hayley Bennett, Phil McEwan, Daniel Sugrue, et al.
International Journal of Clinical Practice
|
December 17, 2020
Risk factors associated with the incidence and recurrence of hyperkalaemia in patients with cardiorenal conditions
Eskinder Tafesse, Michael Hurst, Louise Hoskin, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
October 20, 2020
Serum potassium as a predictor of adverse clinical outcomes in patients with increasing comorbidity burden
Eskinder Tafesse, Michael Hurst, Daniel Sugrue, et al.
Renal Failure
|
January 22, 2021
The effect of hyperkalemia and long inter-dialytic interval on morbidity and mortality in patients receiving hemodialysis: a systematic review
Danai Bem, Daniel Sugrue, Ben Wilding, et al.
The Journal of General Virology
|
January 8, 2014
Human cytomegalovirus suppresses Fas expression and function
Sepehr Seirafian, Virginie Prod'homme, Daniel Sugrue, et al.
Journal of Managed Care & Specialty Pharmacy
|
February 4, 2020
Estimating HIV Management and Comorbidity Costs Among Aging HIV Patients in the United States: A Systematic Review
Thomas Ward, Daniel Sugrue, Olivia Hayward, et al.
Advances in Therapy
|
January 12, 2021
Costs and Healthcare Resource Use Associated with Risk of Cardiovascular Morbidity in Patients with Chronic Kidney Disease: Evidence from a Systematic Literature Review
Oliver Darlington, Carissa Dickerson, Marc Evans, et al.
BMC Rheumatology
|
February 4, 2021
Outcomes in rheumatoid arthritis patients treated with abatacept: a UK multi-centre observational study
Ernest Choy, Lara Groves, Daniel Sugrue, et al.
Plos Pathogens
|
April 16, 2015
Plasma membrane profiling defines an expanded class of cell surface proteins selectively targeted for degradation by HCMV US2 in cooperation with UL141
Jye-Lin Hsu, Dick J H van den Boomen, Peter Tomasec, et al.
Plos Pathogens
|
May 3, 2014
Two novel human cytomegalovirus NK cell evasion functions target MICA for lysosomal degradation
Ceri A Fielding, Rebecca Aicheler, Richard J Stanton, et al.
Page
of 2